TD Cowen on Ionis Pharmaceuticals (IONS): 'New Launches And Key Pipeline Catalysts To Drive Upside'
Tweet Send to a Friend
TD Cowen analyst Yaron Werber reiterated a Buy rating and $99.00 price target on Ionis Pharmaceuticals (NASDAQ: IONS).The analyst commented ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
